Science Explorer Back to mapMap
Discussion
Company · Marseille · France

Innate Pharma (France)

innate-pharma.com/en/introductionROR OpenAlex
World rank, all time
#18,076
of 34,923
Rank in France
#551
of 943
Research works
224
▼ 22% vs 2018-21
Citations
7.3k
32.5 per fractional work
Top-10% rate
13.9%
all institutions 10.0%
vs its own fields
0.97×
1.00× is exactly expected
Open access
32%
world 40%
International
41%
world 18%
Innate Pharma (France)

Which fields of science does Innate Pharma (France) work in?

In 2022-now, 44% of research at Innate Pharma (France) is in Life Sciences, 41% in Health Sciences. Its largest fields are Medicine (41%), Immunology and Microbiology (28%), Biochemistry, Genetics and Molecular Biology (14%). It does 2.2× the world's share of Life Sciences.

Life Sciences: 10 fractional works · 44.4% of its workImmunology and Microbiology: 6 fractional works · 27.8% of its workImmunology: 6 fractional works · 27.4% of its workMicrobiology: 0 fractional works · 0.2% of its workVirology: 0 fractional works · 0.2% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 13.6% of its workMolecular Biology: 2 fractional works · 9.2% of its workPhysiology: 0 fractional works · 1.9% of its workCancer Research: 0 fractional works · 0.7% of its workCell Biology: 0 fractional works · 0.5% of its workMolecular Medicine: 0 fractional works · 0.5% of its workBiotechnology: 0 fractional works · 0.4% of its workBiochemistry: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 0 fractional works · 1.6% of its workCellular and Molecular Neuroscience: 0 fractional works · 1.1% of its workNeurology: 0 fractional works · 0.5% of its workAgricultural and Biological Sciences: 0 fractional works · 0.9% of its workAquatic Science: 0 fractional works · 0.4% of its workPlant Science: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.5% of its workPharmaceutical Science: 0 fractional works · 0.5% of its workHealth Sciences: 9 fractional works · 41.0% of its workMedicine: 9 fractional works · 40.7% of its workOncology: 3 fractional works · 15.0% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 4.6% of its workInfectious Diseases: 1 fractional works · 4.4% of its workPathology and Forensic Medicine: 1 fractional works · 3.0% of its workPulmonary and Respiratory Medicine: 1 fractional works · 2.5% of its workHematology: 0 fractional works · 1.7% of its workGenetics: 0 fractional works · 1.5% of its workSurgery: 0 fractional works · 1.4% of its workRheumatology: 0 fractional works · 1.3% of its workDermatology: 0 fractional works · 1.1% of its workPharmacology: 0 fractional works · 0.7% of its workEpidemiology: 0 fractional works · 0.6% of its workOtorhinolaryngology: 0 fractional works · 0.6% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.5% of its workImmunology and Allergy: 0 fractional works · 0.3% of its workPsychiatry and Mental health: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.7% of its workHealth Professions: 0 fractional works · 0.1% of its workVeterinary: 0 fractional works · 0.1% of its workPhysical Sciences: 2 fractional works · 9.5% of its workEnvironmental Science: 1 fractional works · 2.9% of its workWater Science and Technology: 0 fractional works · 1.6% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.7% of its workEcology: 0 fractional works · 0.6% of its workComputer Science: 0 fractional works · 2.2% of its workComputational Theory and Mathematics: 0 fractional works · 2.2% of its workEngineering: 0 fractional works · 1.9% of its workBiomedical Engineering: 0 fractional works · 1.2% of its workElectrical and Electronic Engineering: 0 fractional works · 0.7% of its workChemistry: 0 fractional works · 1.5% of its workOrganic Chemistry: 0 fractional works · 1.5% of its workMathematics: 0 fractional works · 0.6% of its workStatistics and Probability: 0 fractional works · 0.6% of its workMaterials Science: 0 fractional works · 0.3% of its workMaterials Chemistry: 0 fractional works · 0.3% of its workSocial Sciences: 1 fractional works · 5.1% of its workPsychology: 1 fractional works · 3.3% of its workSocial Psychology: 0 fractional works · 1.6% of its workClinical Psychology: 0 fractional works · 1.2% of its workApplied Psychology: 0 fractional works · 0.5% of its workSocial Sciences: 0 fractional works · 1.3% of its workSociology and Political Science: 0 fractional works · 0.9% of its workGender Studies: 0 fractional works · 0.4% of its workBusiness, Management and Accounting: 0 fractional works · 0.5% of its workAccounting: 0 fractional works · 0.5% of its workALL ITS WORKInnate Pharma(France)23fractional works, 2022-now
Life Sciences44%Physical Sciences10%Health Sciences41%Social Sciences5%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 17 fields, with their numbers
    1. Immunology and Microbiology627.8%
    2. Biochemistry, Genetics and Molecular Biology313.6%
    3. Neuroscience01.6%
    4. Agricultural and Biological Sciences00.9%
    5. Pharmacology, Toxicology and Pharmaceutics00.5%
    1. Medicine940.7%
    2. Health Professions00.1%
    3. Veterinary00.1%
    1. Environmental Science12.9%
    2. Computer Science02.2%
    3. Engineering01.9%
    4. Chemistry01.5%
    5. Mathematics00.6%
    6. Materials Science00.3%
    1. Psychology13.3%
    2. Social Sciences01.3%
    3. Business, Management and Accounting00.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.20× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.54× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 27.66× its world share, 6 worksImmunology and Micro…Neuroscience: 0.97× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.38× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.98× its world share, 0 worksChemistryComputer Science: 0.28× its world share, 0 worksComputer ScienceEngineering: 0.13× its world share, 0 worksEngineeringEnvironmental Science: 0.59× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.08× its world share, 0 worksMaterials ScienceMathematics: 0.53× its world share, 0 worksMathematicsHealth Professions: 0.06× its world share, 0 worksHealth ProfessionsMedicine: 2.12× its world share, 9 worksMedicineVeterinary: 1.11× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.17× its world share, 0 worksBusiness, Management…Psychology: 1.08× its world share, 1 worksPsychologySocial Sciences: 0.10× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 27.7×. Every wedge is a field page.

All 17 fields, with their numbers
  1. Immunology and Microbiology27.66×6 works
  2. Biochemistry, Genetics and Molecular Biology2.54×3 works
  3. Medicine2.12×9 works
  4. Pharmacology, Toxicology and Pharmaceutics1.38×0 works
  5. Veterinary1.11×0 works
  6. Psychology1.08×1 works
  7. Chemistry0.98×0 works
  8. Neuroscience0.97×0 works
  9. Environmental Science0.59×1 works
  10. Mathematics0.53×0 works
  11. Computer Science0.28×0 works
  12. Agricultural and Biological Sciences0.20×0 works
  13. Business, Management and Accounting0.17×0 works
  14. Engineering0.13×0 works
  15. Social Sciences0.10×0 works
  16. Materials Science0.08×0 works
  17. Health Professions0.06×0 works

Who are the top researchers at Innate Pharma (France)?

Ranked on the quality score, Romain Remark, Laurent Gauthier and François Romagné lead among researchers whose main affiliation is Innate Pharma (France).

  1. 1 Romain Remark France · #47,288 worldwide 12k citations · 124 works
  2. 2 Laurent Gauthier France · #270,979 worldwide 5.8k citations · 78 works
  3. 3 François Romagné France · #285,218 worldwide 8.2k citations · 142 works
  4. 4 Yannis Morel France · #298,978 worldwide 6.2k citations · 103 works
  5. 5 Pascale André France · #374,009 worldwide 8.9k citations · 120 works
  6. 6 Mathieu Bléry France · #459,489 worldwide 5.1k citations · 68 works
  7. 7 Ariane Morel France · #528,851 worldwide 2.6k citations · 34 works
  8. 8 Carine Paturel France · #603,684 worldwide 2.3k citations · 72 works
  9. 9 Guillaume Habif France · #701,586 worldwide 2.6k citations · 23 works
  10. 10 Cécile Bonnafous France · #913,098 worldwide 2.8k citations · 73 works
All ranked researchers at Innate Pharma (France)

What are the most cited papers from Innate Pharma (France)?

The most cited paper from Innate Pharma (France) is "Innate Lymphoid Cells: 10 Years On" (Eric D. Vivier, David Artis, Marco Colonna et al., 2018), with 2,174 citations. Next come "Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells" (1,233) and "Human NK Cell Education by Inhibitory Receptors for MHC Class I" (1,182).

Most cited papers
#PaperReleasedCitations
1 Innate Lymphoid Cells: 10 Years On Eric D. Vivier, David Artis, Marco Colonna et al. · Cell Open access Aug 2018 2,174
2 Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells Pascale André et al. · Cell Open access 29 Nov 2018 1,233
3 Human NK Cell Education by Inhibitory Receptors for MHC Class I Nicolas Anfossi, Pascale André, Sophie Guia et al. · Immunity Open access Aug 2006 1,182
4 Natural killer cells and other innate lymphoid cells in cancer Laura Chiossone, Pierre‐Yves Dumas, Margaux Vienne et al. · Nature reviews. Immunology Review 12 Sep 2018 1,040
5 Single-cell immune landscape of human atherosclerotic plaques Dawn M. Fernandez et al. · Nature Medicine Open access Oct 2019 1,014
All 60 most cited papers, with filters and sorting

Which keywords describe research at Innate Pharma (France)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Lymphoma, Immunotherapy, Natural Killer Cells, NK Cell Recognition, Cancer Immunotherapy, Leukemia, Tumor Regression and Cancer.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 16 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 16 words, with their numbers
  1. Lymphoma3▲ 70×3 topics
  2. Immunotherapy2▲ 15×9 topics
  3. NK Cell Recognition2▲ 170×1 topic
  4. Natural Killer Cells2▲ 170×1 topic
  5. Cancer2▲ 6.6×11 topics
  6. Cancer Immunotherapy2▲ 58×3 topics
  7. Inflammation2▲ 4.2×14 topics
  8. Leukemia2▲ 105×2 topics
  9. Tumor Regression2▲ 77×2 topics
  10. CAR T Cells2▲ 112×1 topic
  11. Chimeric Antigen Receptor2▲ 112×1 topic
  12. Glycosylation2▲ 66×3 topics
  13. Autoimmunity1▲ 43×3 topics
  14. Tumor Microenvironment1▲ 12×5 topics
  15. Epidemiology1▲ 1.19×9 topics
  16. Targeted Therapy1▲ 20×5 topics

Which research topics does Innate Pharma (France) publish most on?

By volume in 2022-now: Immune Cell Function and Interaction, CAR-T cell therapy research, Glycosylation and Glycoproteins Research and Monoclonal and Polyclonal Antibodies Research.

Immune Cell Function and…2Immune Cell Function and Interaction: 2 fractional worksCAR-T cell therapy research: 2 fractional worksGlycosylation and Glycoproteins Research: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksGalectins and Cancer Bio…1Galectins and Cancer Biology: 1 fractional worksT-cell and B-cell Immunology: 1 fractional worksLymphoma Diagnosis and Treatment: 1 fractional worksToxin Mechanisms and Immunotoxins: 0 fractional worksMathematics, Computing, and Information Processing: 0 fractional works
ImmunologyOncologyMolecular BiologyRadiology, Nuclear Medicine and Imaging2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Immune Cell Function and Interaction Immunology 2 works
  2. 2 CAR-T cell therapy research Oncology 2 works
  3. 3 Glycosylation and Glycoproteins Research Molecular Biology 1 works
  4. 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  5. 5 Cancer Immunotherapy and Biomarkers Oncology 1 works
  6. 6 Galectins and Cancer Biology Immunology 1 works
  7. 7 T-cell and B-cell Immunology Immunology 1 works
  8. 8 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
  9. 9 Toxin Mechanisms and Immunotoxins Immunology 0 works
  10. 10 Mathematics, Computing, and Information Processing Computational Theory and Mathematics 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available32.3%not open67.7%

World: 40% of research is openly available.

with international co-authors41.0%domestic only59.0%

World: 18% is written across borders.

How has Innate Pharma (France)'s research output changed?

Output in 2022-2025 was 22% lower than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Innate Pharma (France) as a percentage of every work published that year, 0.00012% in 2024.

still counting0.00050%0.0010%0.0015%Innate Pharma (France)0.00013% in 2025200020102020

Fractional works of Innate Pharma (France) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Marseille

All research institutions in Marseille

Share Innate Pharma (France)'s ranking

Innate Pharma (France) on Science Explorer

A card with Innate Pharma (France)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Innate Pharma (France). Posts are plain text and can be reported.